USPH vs ASTH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 10, 2026

USPH

43.0
AI Score
VS
ASTH Wins

ASTH

46.4
AI Score

Investment Advisor Scores

USPH

43score
Recommendation
HOLD

ASTH

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric USPH ASTH Winner
Revenue 634.90M 2.96B ASTH
Net Income 25.98M 47.13M ASTH
Net Margin 4.1% 1.6% USPH
Operating Income 59.53M 102.73M ASTH
ROE 6.1% 5.5% USPH
ROA 2.0% 2.0% ASTH
Total Assets 1.30B 2.34B ASTH
Cash 38.23M 396.23M ASTH
Debt/Equity 0.56 1.01 USPH
Current Ratio 1.42 1.25 USPH

Relative Price Performance (Last 90 Days)

USPH 1M: +15.5% · 3M: +21.1% ASTH 1M: -16.2% · 3M: -10.1%

Current Technical Phase

USPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 75

RSI (14): 75.0 · Price: $99.24

ASTH

Markdown
Sell / avoid

Price below a falling SMA50 (slope -0.8%), weak momentum, RSI 34

RSI (14): 33.7 · Price: $32.18

Fundamentals Snapshot

Metric USPH ASTH
Market Cap — —
Forward P/E 29.6 8.9
Trailing P/E — 31.9
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.2% 0.1%
Operating Margin 0.1% 0.0%
EPS -1.33 1.06
Dividend Yield 0.02% —

Frequently Asked Questions

Based on our detailed analysis, ASTH is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.